Bulletin de Périodique
Addiction , Vol.119, n°11 - November 2024
Paru le :
01/11/2024
Année
2024
Page(s) :
1857-2040
Langue(s) :
Anglais
Discipline :
SOM (Sommaire de périodique / Journal contents)
Note de contenu :
CONTENTS:
- Managing the exponential growth of Mendelian randomization studies [Editorial]. Munafo M.R., Brown J., Hefler M., Davey Smith G., p. 1861-1863.
- E-cigarettes: A framework for comparative history and policy [Addiction opinion and debate]. Berridge V., Fairchild A.L., Morphett K., Gartner C., Hall W., Bayer R., p. 1864-1870.
- E-cigarette policies in Aotearoa (New Zealand): An Indigenous perspective. Waa A., p. 1871-1872.
- Adopting the Berridge et al.: Framework to understand differences in the e-cigarette policy between the Nordic countries. Lund K.E., Saebo G., p. 1873-1874.
- A tobacco control policy analysis framework that extends into the future. Deguchi T.K., Tabuchi T., p. 1875-1876.
- Evidence and policy is certainly more complex than it seems. Berridge V., Hall W., Morphett K., Fairchild A., Bayer R., Gartner C., p. 1877-1878.
- Pain in people seeking and receiving opioid agonist treatment: A systematic review and meta-analysis of prevalence and correlates. Yang J., Jung M., Picco L., Grist E., Lloyd-Jones M., Giummarra M., et al., p. 1879-1901.
- Commentary on Yang et al.: The need for a renewed focus on identifying and responding to chronic pain among people with substance use disorders. Campbell G., Larance B., p. 1902-1903.
- Prevalence of problematic pharmaceutical opioid use in patients with chronic non-cancer pain: A systematic review and meta-analysis. Thomas K.H., Dalili M.N., Cheng H.Y., Dawson S., Donnelly N., Higgins J.P.T., et al., p. 1904-1922.
- The effect of tobacco tax increase on price-minimizing tobacco purchasing behaviours: A systematic review and meta-analysis. Cho A., Lim C., Sun T., Chan G., Gartner C., p. 1923-1936.
- Mega-analysis of the brain-age gap in substance use disorder: An ENIGMA Addiction working group study. Scheffler F., Ipser J., Pancholi D., Murphy A., Cao Z., Ottino-Gonzalez J., et al., p. 1937-1946.
- Association between adolescent alcohol use and cognitive function in young adulthood: A co-twin comparison study. Cooke M.E., Stephenson M., Brislin S.J., Latvala A., Barr P.B., Piirtola M., et al., p. 1947-1955.
- Harm to children from others' drinking: A survey of caregivers in Australia. Hopkins C., Kuntsche S., Dwyer R., Anderson-Luxford D., Laslett A.M., p. 1956-1963.
- Dose-specific clinical outcomes in patients with opioid use disorder treated with 24-32?mg/day of buprenorphine. D'Agata Mount J., Sun J., Davis A., Cover A., Sun L., Gannon C., et al., p. 1964-1972.
- Commentary on D'Agata Mount et al.: Higher dose buprenorphine to improve retention in opioid use disorder treatment, prevent relapse, and optimize integrated care interventions. Mannelli P., p. 1973-1974.
- Comparative effectiveness of extended-release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patients. Ross R.K., Nunes E.V., Olfson M., Shulman M., Krawczyk N., Stuart E.A., et al., p. 1975-1986.
- Association of psychiatric and substance use disorders with cannabis use and cannabis use disorder during early pregnancy in northern California. Young-Wolff K.C., Chi F.W., Campbell C.I., Does M.B., Brown Q.L., Alexeeff S.E., et al., p. 1987-1997.
- Cannabis policy bundles and traffic fatalities in the American States over time. Park M., Mallinson D.J., Altaf S., Richardson L.E., Jr., p. 1998-2005.
- Trends and adverse pregnancy and birth outcomes associated with stimulant-related disorder diagnosis. Pippard N.S., Bandoli G., Baer R.J., p. 2006-2014.
- Somatic and psychiatric comorbidity in people with diagnosed gambling disorder: A Finnish nation-wide register study. Grönroos T., Kontto J., Kouvonen A., Latvala T.A., Partonen T., Salonen A.H., p. 2015-2022.
- Nicotine pouch use by sex, school type and tobacco product use among Finnish adolescents during the 2023 change in regulatory scheme with deregulated sales. Ruokolainen O., Ollila H., Härkänen T., p. 2023-2030.
- Alcohol-specific inpatient diagnoses in Germany: A retrospective cross-sectional analysis of primary and secondary diagnoses from 2012 to 2021. Manthey J., Jacobsen B., Kilian C., Kraus L., Reimer J., Schäfer I., et al., p. 2031-2037.
- Managing the exponential growth of Mendelian randomization studies [Editorial]. Munafo M.R., Brown J., Hefler M., Davey Smith G., p. 1861-1863.
- E-cigarettes: A framework for comparative history and policy [Addiction opinion and debate]. Berridge V., Fairchild A.L., Morphett K., Gartner C., Hall W., Bayer R., p. 1864-1870.
- E-cigarette policies in Aotearoa (New Zealand): An Indigenous perspective. Waa A., p. 1871-1872.
- Adopting the Berridge et al.: Framework to understand differences in the e-cigarette policy between the Nordic countries. Lund K.E., Saebo G., p. 1873-1874.
- A tobacco control policy analysis framework that extends into the future. Deguchi T.K., Tabuchi T., p. 1875-1876.
- Evidence and policy is certainly more complex than it seems. Berridge V., Hall W., Morphett K., Fairchild A., Bayer R., Gartner C., p. 1877-1878.
- Pain in people seeking and receiving opioid agonist treatment: A systematic review and meta-analysis of prevalence and correlates. Yang J., Jung M., Picco L., Grist E., Lloyd-Jones M., Giummarra M., et al., p. 1879-1901.
- Commentary on Yang et al.: The need for a renewed focus on identifying and responding to chronic pain among people with substance use disorders. Campbell G., Larance B., p. 1902-1903.
- Prevalence of problematic pharmaceutical opioid use in patients with chronic non-cancer pain: A systematic review and meta-analysis. Thomas K.H., Dalili M.N., Cheng H.Y., Dawson S., Donnelly N., Higgins J.P.T., et al., p. 1904-1922.
- The effect of tobacco tax increase on price-minimizing tobacco purchasing behaviours: A systematic review and meta-analysis. Cho A., Lim C., Sun T., Chan G., Gartner C., p. 1923-1936.
- Mega-analysis of the brain-age gap in substance use disorder: An ENIGMA Addiction working group study. Scheffler F., Ipser J., Pancholi D., Murphy A., Cao Z., Ottino-Gonzalez J., et al., p. 1937-1946.
- Association between adolescent alcohol use and cognitive function in young adulthood: A co-twin comparison study. Cooke M.E., Stephenson M., Brislin S.J., Latvala A., Barr P.B., Piirtola M., et al., p. 1947-1955.
- Harm to children from others' drinking: A survey of caregivers in Australia. Hopkins C., Kuntsche S., Dwyer R., Anderson-Luxford D., Laslett A.M., p. 1956-1963.
- Dose-specific clinical outcomes in patients with opioid use disorder treated with 24-32?mg/day of buprenorphine. D'Agata Mount J., Sun J., Davis A., Cover A., Sun L., Gannon C., et al., p. 1964-1972.
- Commentary on D'Agata Mount et al.: Higher dose buprenorphine to improve retention in opioid use disorder treatment, prevent relapse, and optimize integrated care interventions. Mannelli P., p. 1973-1974.
- Comparative effectiveness of extended-release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patients. Ross R.K., Nunes E.V., Olfson M., Shulman M., Krawczyk N., Stuart E.A., et al., p. 1975-1986.
- Association of psychiatric and substance use disorders with cannabis use and cannabis use disorder during early pregnancy in northern California. Young-Wolff K.C., Chi F.W., Campbell C.I., Does M.B., Brown Q.L., Alexeeff S.E., et al., p. 1987-1997.
- Cannabis policy bundles and traffic fatalities in the American States over time. Park M., Mallinson D.J., Altaf S., Richardson L.E., Jr., p. 1998-2005.
- Trends and adverse pregnancy and birth outcomes associated with stimulant-related disorder diagnosis. Pippard N.S., Bandoli G., Baer R.J., p. 2006-2014.
- Somatic and psychiatric comorbidity in people with diagnosed gambling disorder: A Finnish nation-wide register study. Grönroos T., Kontto J., Kouvonen A., Latvala T.A., Partonen T., Salonen A.H., p. 2015-2022.
- Nicotine pouch use by sex, school type and tobacco product use among Finnish adolescents during the 2023 change in regulatory scheme with deregulated sales. Ruokolainen O., Ollila H., Härkänen T., p. 2023-2030.
- Alcohol-specific inpatient diagnoses in Germany: A retrospective cross-sectional analysis of primary and secondary diagnoses from 2012 to 2021. Manthey J., Jacobsen B., Kilian C., Kraus L., Reimer J., Schäfer I., et al., p. 2031-2037.
Cote :
Abonnement
Dépouillements
Ajouter le résultat à votre sélection
V. BERRIDGE ;
A. L. FAIRCHILD ;
K. MORPHETT ;
C. GARTNER ;
W. HALL ;
R. BAYER
|
2024
Dans Addiction (Vol.119, n°11, November 2024) Article : Périodique
Dans Addiction (Vol.119, n°11, November 2024) Article : Périodique
BACKGROUND: England, Australia and the United States have approached the regulation of e-cigarettes in very different ways, yet all three countries have appealed to the concept of evidence as underpinning policy responses. We compared these poli[...]
A. CHO ;
C. LIM ;
T. SUN ;
G. CHAN ;
C. GARTNER
|
2024
Dans Addiction (Vol.119, n°11, November 2024) Article : Périodique
Dans Addiction (Vol.119, n°11, November 2024) Article : Périodique
BACKGROUND AND AIMS: Tobacco product excise taxes are a cost-effective method for reducing tobacco consumption, but industry pricing and marketing strategies encourage consumers to engage in price-minimizing behaviours (PMBs). We investigated th[...]
R. K. ROSS ;
E. V. NUNES ;
M. OLFSON ;
M. SHULMAN ;
N. KRAWCZYK ;
E. A. STUART ;
K. E. RUDOLPH
|
2024
Dans Addiction (Vol.119, n°11, November 2024) Article : Périodique
Dans Addiction (Vol.119, n°11, November 2024) Article : Périodique
BACKGROUND AND AIMS: Extended-release naltrexone (XR-NTX) and sublingual buprenorphine (SL-BUP) are both approved for opioid use disorder (OUD) treatment in any medical setting. We aimed to compare the real-world effectiveness of XR-NTX and SL-B[...]
Historique